Target Name: NUDT4
NCBI ID: G11163
Review Report on NUDT4 Target / Biomarker Content of Review Report on NUDT4 Target / Biomarker
NUDT4
Other Name(s): nudix (nucleoside diphosphate linked moiety X)-type motif 4 | diphosphoinositol polyphosphate phosphohydrolase type 2 | diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2 | DIPP2 | DIPP-2B | Nudix hy

NUDT4: A Potential Drug Target and Biomarker

Nucleoside diphosphate linked moiety X (NUDT4) is a protein that has been identified as a potential drug target and biomarker. NUDT4 is a key regulator of DNA replication and has been involved in various cellular processes, including cell growth, apoptosis, and transcription. Its function and regulation have been studied extensively, and its potential as a drug target has been evaluated in various models. In this article, we will summarize the current understanding of NUDT4, its potential as a drug target, and its potential as a biomarker.

NUDT4: A Key Regulator of DNA Replication

NUDT4 is a protein that is expressed in various tissues and has been shown to play a critical role in regulating DNA replication. It is a key regulator of the DNA replication machinery and is involved in the initiation of DNA replication. NUDT4 has been shown to interact with the enzyme responsible for initiating DNA replication, DnaB, and it is thought to play a role in the allocation of the necessary resources for DNA replication.

In addition to its role in DNA replication, NUDT4 is also involved in the regulation of cell apoptosis. NUDT4 has been shown to be involved in the regulation of cell apoptosis and has been shown to play a role in the sensitivity of cancer cells to chemotherapy.

Potential as a Drug Target

NUDT4 has been identified as a potential drug target due to its involvement in various cellular processes and its critical role in regulating DNA replication. NUDT4 has been shown to be involved in the regulation of cell growth, apoptosis, and transcription, and its function as a drug target has been evaluated in various models.

One of the potential mechanisms by which NUDT4 can be targeted is through its role in cell growth and apoptosis. NUDT4 has been shown to play a role in the regulation of cell growth and has been shown to be involved in the regulation of cell apoptosis. Its inhibition has been shown to result in the inhibition of cell growth and the inhibition of cell apoptosis.

Another potential mechanism by which NUDT4 can be targeted is through its role in transcription. NUDT4 has been shown to play a role in the regulation of gene expression and has been shown to be involved in the regulation of transcription. Its inhibition has been shown to result in the inhibition of gene expression.

Potential as a Biomarker

NUDT4 has also been identified as a potential biomarker due to its involvement in various cellular processes. NUDT4 has been shown to play a role in the regulation of DNA replication, cell apoptosis, and transcription, and its levels have been shown to be regulated in various diseases.

One of the potential applications of NUDT4 as a biomarker is its potential to be used as a diagnostic marker for cancer. NUDT4 has been shown to be expressed in various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Its levels have also been shown to be regulated in various factors that are associated with cancer, such as age, gender, and environmental factors.

Another potential application of NUDT4 as a biomarker is its potential to be used as a therapeutic target for cancer. NUDT4 has been shown to play a role in the regulation of cell growth, apoptosis, and transcription, and its inhibition has been shown to result in the inhibition of

Protein Name: Nudix Hydrolase 4

Functions: Cleaves a beta-phosphate from the diphosphate groups in PP-InsP5 (diphosphoinositol pentakisphosphate), PP-InsP4 and [PP]2-InsP4 (bisdiphosphoinositol tetrakisphosphate), suggesting that it may play a role in signal transduction. Also able to catalyze the hydrolysis of dinucleoside oligophosphate Ap6A, but not Ap5A. The major reaction products are ADP and p4a from Ap6A. Also able to hydrolyze 5-phosphoribose 1-diphosphate. Does not play a role in U8 snoRNA decapping activity. Binds U8 snoRNA

The "NUDT4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NUDT4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NUDT4B | NUDT4P2 | NUDT5 | NUDT6 | NUDT7 | NUDT8 | NUDT9 | NUDT9P1 | NUF2 | NUFIP1 | NUFIP2 | NUGGC | NUMA1 | NUMB | NUMBL | NUP107 | Nup107-160 complex | NUP133 | NUP153 | NUP155 | NUP160 | NUP188 | NUP205 | NUP210 | NUP210L | NUP210P1 | NUP210P2 | NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A